Intuitive Surgical stock surges 10% amid da Vinci 5 demand, with full rollout set for 2025

Earlier this year, Intuitive Surgical warned that supplies may be tight in the months ahead as it continues to roll out the latest iteration of its da Vinci robot. And, while the company has made some gains—installing some 110 da Vinci 5 systems in the third quarter of this year, versus 70 in the quarter prior—Intuitive held to its previous timeline, saying it plans to have production scaled up and running up for a broader launch in mid-2025.

GSK and Boston scientists team up to study pulmonary fibrosis and develop new treatments

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. The Big Pharma is joining forces with researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center to develop new models for lung diseases like pulmonary fibrosis, the researchers announced in an Oct. 17 release.

error: Content is protected !!